Skip to main content

Life Sciences

HIMSS22
By Laura Lovett | 12:30 pm | March 03, 2022
UMPC's chief pharmacy officer Chronis Manolis discusses the future of pharmacies ahead of HIMSS22. 
By Emily Olsen | 02:00 pm | March 02, 2022
The agreement also allows the companies to develop new or improved tools for Dario's chronic condition management platform.
By Laura Lovett | 02:26 pm | February 28, 2022
Preliminary data from the women's health study shows individuals with PCOS are more likely to have Type 2 diabetes and obesity than those without the condition.
By Tammy Lovell | 08:30 am | February 22, 2022
Automata aims to scale capacities for life scientists.
By Laura Lovett | 03:05 pm | February 18, 2022
The lab, which works with AstraZeneca, Merck, Pfizer, Israel Biotech Fund, Teva Pharmaceuticals, and Amazon Web Services, is currently accepting applicants for its new challenge. 
By Emily Olsen | 01:24 pm | February 17, 2022
The healthcare professional networking and data company said the deal will give its users access to the latest research in biology and medicine.
By Adam Ang | 05:14 am | February 17, 2022
The company is focusing on its expansion across Asia and the UK.
HIMSS22
By Emily Olsen | 03:01 pm | February 16, 2022
In a preview of her HIMSS22 session, Abbott's Jennifer Jones-McMeans explains how clinical studies can be structured to ensure a diverse population of participants.
By Emily Olsen | 03:36 pm | February 15, 2022
Also: Complex-care-management platform Memora Health and digital-fitness startup FitOn both raised $40 million.
By Adam Ang | 12:17 am | February 15, 2022
The telehealth service is expanding across Asia two years since its launch in Singapore.